135 related articles for article (PubMed ID: 26618447)
1. Metformin Decreases Thyroid Volume and Nodule Size in Subjects with Insulin Resistance: A Preliminary Study.
Anil C; Kut A; Atesagaoglu B; Nar A; Bascil Tutuncu N; Gursoy A
Med Princ Pract; 2016; 25(3):233-6. PubMed ID: 26618447
[TBL] [Abstract][Full Text] [Related]
2. Role of Metformin in the Treatment of Patients with Thyroid Nodules and Insulin Resistance: A Systematic Review and Meta-Analysis.
He X; Wu D; Hu C; Xu T; Liu Y; Liu C; Xu B; Tang W
Thyroid; 2019 Mar; 29(3):359-367. PubMed ID: 30595105
[TBL] [Abstract][Full Text] [Related]
3. Metformin treatment for small benign thyroid nodules in patients with insulin resistance.
Rezzónico J; Rezzónico M; Pusiol E; Pitoia F; Niepomniszcze H
Metab Syndr Relat Disord; 2011 Feb; 9(1):69-75. PubMed ID: 21128816
[TBL] [Abstract][Full Text] [Related]
4. Comment on "Metformin Decreases Thyroid Volume and Nodule Size in Subjects with Insulin Resistance: A Preliminary Study".
Cintosun U; Naharci MI; Doruk H
Med Princ Pract; 2017; 26(2):199-200. PubMed ID: 27802445
[No Abstract] [Full Text] [Related]
5. Metformin in the treatment of obesity in subjects with normal glucose tolerance.
Tankova T; Dakovska L; Kirilov G; Koev D
Rom J Intern Med; 2003; 41(3):269-75. PubMed ID: 15526510
[TBL] [Abstract][Full Text] [Related]
6. Effect of metformin compared with hypocaloric diet on serum C-reactive protein level and insulin resistance in obese and overweight women with polycystic ovary syndrome.
Esfahanian F; Zamani MM; Heshmat R; Moini nia F
J Obstet Gynaecol Res; 2013 Apr; 39(4):806-13. PubMed ID: 23279603
[TBL] [Abstract][Full Text] [Related]
7. Relationship between thyroid nodules and non-functioning adrenal incidentalomas and their association with insulin resistance.
Arduc A; Isik S; Ozuguz U; Tutuncu YA; Kucukler FK; Ozcan HN; Berker D; Guler S
Endocr Res; 2014; 39(3):99-104. PubMed ID: 24152247
[TBL] [Abstract][Full Text] [Related]
8. The effect of Metformin treatment in obese insulin-resistant patients with euthyroid goiter.
Răcătăianu N; Bolboacă SD; Sitar-Tăut AV; Mârza S; Moga D; Valea A; Ghervan C
Acta Clin Belg; 2018 Oct; 73(5):317-323. PubMed ID: 29452573
[TBL] [Abstract][Full Text] [Related]
9. Metformin for overweight women at midlife: a double-blind, randomized, controlled trial.
Worsley R; Jane F; Robinson PJ; Bell RJ; Davis SR
Climacteric; 2015 Apr; 18(2):270-7. PubMed ID: 25333776
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area.
Ayturk S; Gursoy A; Kut A; Anil C; Nar A; Tutuncu NB
Eur J Endocrinol; 2009 Oct; 161(4):599-605. PubMed ID: 19633072
[TBL] [Abstract][Full Text] [Related]
11. Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial.
Wu RR; Zhao JP; Jin H; Shao P; Fang MS; Guo XF; He YQ; Liu YJ; Chen JD; Li LH
JAMA; 2008 Jan; 299(2):185-93. PubMed ID: 18182600
[TBL] [Abstract][Full Text] [Related]
12. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
13. An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet.
Glueck CJ; Goldenberg N; Sieve L; Wang P
Metabolism; 2008 Jul; 57(7):954-60. PubMed ID: 18555837
[TBL] [Abstract][Full Text] [Related]
14. Metformin decreases thyrotropin in overweight women with polycystic ovarian syndrome and hypothyroidism.
Morteza Taghavi S; Rokni H; Fatemi S
Diab Vasc Dis Res; 2011 Jan; 8(1):47-8. PubMed ID: 21262871
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effect of orlistat vs orlistat plus metformin on weight loss and insulin resistance in obese women.
Sari R; Balci MK; Coban E; Yazicioglu G
Int J Obes Relat Metab Disord; 2004 Aug; 28(8):1059-63. PubMed ID: 15211369
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of metformin in abdominal obesity].
Mkrtumian AM; Markova TN; Kichigin VA; Podachina SV; Zhuchkova SM
Ter Arkh; 2014; 86(8):80-4. PubMed ID: 25306749
[TBL] [Abstract][Full Text] [Related]
17. Metformin versus rosiglitazone in the treatment of polycystic ovary syndrome.
Mitkov M; Pehlivanov B; Terzieva D
Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):93-8. PubMed ID: 16360262
[TBL] [Abstract][Full Text] [Related]
18. Insulin resistance in nodular thyroid disease.
Yasar HY; Ertuğrul O; Ertuğrul B; Ertuğrul D; Sahin M
Endocr Res; 2011; 36(4):167-74. PubMed ID: 21973236
[TBL] [Abstract][Full Text] [Related]
19. Are the beneficial cardiovascular effects of simvastatin and metformin also associated with a hormone-dependent mechanism improving insulin sensitivity?
Bulcão C; Giuffrida FM; Ribeiro-Filho FF; Ferreira SR
Braz J Med Biol Res; 2007 Feb; 40(2):229-35. PubMed ID: 17273659
[TBL] [Abstract][Full Text] [Related]
20. Effects of GH replacement therapy on thyroid volume and nodule development in GH deficient adults: a retrospective cohort study.
Curtò L; Giovinazzo S; Alibrandi A; Campennì A; Trimarchi F; Cannavò S; Ruggeri RM
Eur J Endocrinol; 2015 May; 172(5):543-52. PubMed ID: 25646405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
